Oak Ridge Investments’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-13,808
| Closed | -$1.77M | – | 181 |
|
|
2025
Q2 | $1.77M | Sell |
13,808
-739
| -5% | -$76.8K | 0.13% | 95 |
|
|
2025
Q1 | $1.29M | Buy |
14,547
+350
| +2% | +$34.1K | 0.11% | 106 |
|
|
2024
Q4 | $1.24M | Sell |
14,197
-938
| -6% | -$85.9K | 0.1% | 109 |
|
|
2024
Q3 | $1.4M | Sell |
15,135
-609
| -4% | -$60.5K | 0.12% | 97 |
|
|
2024
Q2 | $1.7M | Buy |
15,744
+3,555
| +29% | +$356K | 0.16% | 97 |
|
|
2024
Q1 | $1.16M | Buy |
12,189
+72
| +0.6% | +$6.17K | 0.12% | 116 |
|
|
2023
Q4 | $1.12M | Sell |
12,117
-1,709
| -12% | -$111K | 0.13% | 119 |
|
|
2023
Q3 | $694K | Sell |
13,826
-447
| -3% | -$23.9K | 0.09% | 127 |
|
|
2023
Q2 | $902K | Sell |
14,273
-490
| -3% | -$26.6K | 0.11% | 128 |
|
|
2023
Q1 | $664K | Sell |
14,763
-442
| -3% | -$19.9K | 0.09% | 129 |
|
|
2022
Q4 | $666K | Sell |
15,205
-862
| -5% | -$41.3K | 0.1% | 130 |
|
|
2022
Q3 | $1.06M | Buy |
16,067
+193
| +1% | +$12.4K | 0.16% | 124 |
|
|
2022
Q2 | $802K | Sell |
15,874
-1,250
| -7% | -$73.2K | 0.12% | 128 |
|
|
2022
Q1 | $1.09M | Sell |
17,124
-9,780
| -36% | -$702K | 0.12% | 129 |
|
|
2021
Q4 | $2.88M | Sell |
26,904
-445
| -2% | -$46.5K | 0.24% | 100 |
|
|
2021
Q3 | $2.81M | Sell |
27,349
-628
| -2% | -$58.5K | 0.25% | 106 |
|
|
2021
Q2 | $2.46M | Sell |
27,977
-1,815
| -6% | -$166K | 0.21% | 111 |
|
|
2021
Q1 | $2.9M | Sell |
29,792
-1,392
| -4% | -$139K | 0.27% | 107 |
|
|
2020
Q4 | $3.5M | Sell |
31,184
-7,408
| -19% | -$781K | 0.31% | 104 |
|
|
2020
Q3 | $3.58M | Sell |
38,592
-2,923
| -7% | -$225K | 0.28% | 107 |
|
|
2020
Q2 | $3.24M | Sell |
41,515
-3,739
| -8% | -$253K | 0.27% | 104 |
|
|
2020
Q1 | $2.65M | Sell |
45,254
-2,041
| -4% | -$131K | 0.27% | 101 |
|
|
2019
Q4 | $3.79M | Sell |
47,295
-8,859
| -16% | -$663K | 0.28% | 106 |
|
|
2019
Q3 | $4.13M | Buy |
56,154
+21,020
| +60% | +$1.82M | 0.31% | 96 |
|
|
2019
Q2 | $3.31M | Buy |
+35,134
| New | +$2.9M | 0.23% | 106 |
|
Other funds holding BPMC
IA
HNB
Oak Ridge Investments's BPMC Position: Q3 2025 in Review
Oak Ridge Investments sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 13,808 shares — an estimated $1.77M sold.
Oak Ridge Investments first reported a position in BPMC in Q2 2019 and held it in 25 quarters. The position peaked at $4.13M in Q3 2019. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Oak Ridge Investments reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Oak Ridge Investments sold 13,808 Blueprint Medicines shares in Q3 2025, an estimated $1.77M.
- Oak Ridge Investments first reported a position in Blueprint Medicines in Q2 2019 and held it in 25 quarters.
- Oak Ridge Investments's Blueprint Medicines position peaked at $4.13M in Q3 2019.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Oak Ridge Investments's 13F filing for Q3 2025, filed 29 Oct 2025.